Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
IMGNImmunoGen	$8.72bn	n/a	n/a
PRAXPraxis Precision Medicines	$8.65bn	n/a	n/a
ICLRIcon	$8.45bn	10.89	n/a
PCVXVaxcyte	$8.38bn	n/a	n/a
BPMCBlueprint Medicines	$8.37bn	n/a	n/a
CERECerevel Therapeutics Holdings	$8.19bn	n/a	n/a
NUVLNuvalent	$7.87bn	n/a	n/a
CYTKCytokinetics	$7.66bn	n/a	n/a
MRUSMerus NV	$7.35bn	n/a	n/a
CDTXCidara Therapeutics	$6.95bn	n/a	n/a
KYMRKymera Therapeutics	$6.82bn	n/a	n/a
ACLXArcellx	$6.69bn	n/a	n/a
RETAReata Pharmaceuticals	$6.52bn	n/a	n/a
COGTCogent Biosciences	$6.08bn	n/a	n/a
PTGXProtagonist Therapeutics	$5.83bn	n/a	n/a
MTSRMetsera	$5.58bn	n/a	n/a
ISEEIVERIC bio	$5.51bn	n/a	n/a
CRSPCrispr Therapeutics AG	$5.50bn	n/a	n/a
IMVTImmunovant	$5.44bn	n/a	n/a
CELCCelcuity	$5.33bn	n/a	n/a